ARRB1 and cancer: For this reason, the fact that miR‐326 and ARRB1 appear to exert convergent tumor‐suppressive effects in human MBs is by no means incompatible with its demonstrated oncogenic effects in other cancer cells [71, 73, 74, 75, 76].